Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
56,259,506
-
Share change
-
-556,097
-
Total reported value
-
$3,350,553,829
-
Put/Call ratio
-
63%
-
Price per share
-
$59.55
-
Number of holders
-
229
-
Value change
-
-$55,431,013
-
Number of buys
-
121
-
Number of sells
-
90
Institutional Holders of ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) as of Q3 2021
As of 30 Sep 2021,
ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,259,506 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Avoro Capital Advisors LLC, STATE STREET CORP, ALKEON CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, JANUS HENDERSON GROUP PLC, PICTET ASSET MANAGEMENT SA, and Avidity Partners Management LP.
This page lists
229
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.